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Abstract 
 
The formation of differential cell lineages in the mammalian blastocyst from the 
totipotent zygote is crucial for implantation and the success of the whole 
pregnancy. The first lineage segregation generates the polarised trophectoderm 
(TE) tissue, which forms the placenta, and the apolar inner cell mass (ICM), 
which mainly gives rise to all foetal tissues and also the yolk sac1-3. The 
mechanism underlying this cell fate segregation has been extensively studied 
in the mouse embryo4,5. However, when and how it takes place in the human 
embryo remains unclear. Here, using time-lapse imaging and 325 surplus 
human embryos, we provide a detailed characterisation of morphological 
events and transcription factor expression and localisation to understand how 
they lead to the first lineage segregation in human embryogenesis. We show 
that the first lineage segregation of the human embryo is triggered by cell 
polarisation that occurs at the 8-cell stage in two sequential steps. In the first 
step, F-actin becomes apically polarised concomitantly with embryo 
compaction. In the second step, the Par complex becomes polarised to form the 
apical cellular domain. Mechanistically, we show that activation of 
Phospholipase C (PLC) triggers actin polarisation and is therefore essential for 
apical domain formation, as is the case in mouse embryos6. Finally, we show 
that, in contrast to the mouse embryo, the key extra-embryonic determinant 
GATA37,8 is expressed not only in extra-embryonic lineage precursors upon 
blastocyst formation. However, the cell polarity machinery enhances the 
expression and nuclear accumulation of GATA3. In summary, our results 
demonstrate for the first time that cell polarisation reinforces the first lineage 
segregation in the human embryo.  
 
	
Studies in the mouse embryo demonstrate that the first lineage segregation begins 
with embryo compaction and polarisation on the third day of development (day 2.5) at 
the late 8-cell stage. The processes of compaction and polarisation lead to the closer 
apposition of neighbouring cells and the formation of an apical domain that orients 
towards the outside of the embryo9-11. The differential inheritance of the apical domain 
during the successive cell divisions generates polarised and non-polarised cells that 
sort to the outside and inside of the embryo, respectively12-14. Subsequently, cell 
polarity coordinates with cell position to control the expression of lineage-specific 
transcription factors, allowing the outside polarised cells to adopt TE identity and inner 
non-polarised cells to specify ICM fate5,15. Neither the timing of embryo polarisation, 
the sequence of its events, its mechanism, nor how it affects subsequent cell fate 
decisions in human embryos are known. 	
 
To address these fundamental questions, we first wished to determine the exact timing 
of cell polarisation in relation to compaction in the human embryo. Previous studies of 
human embryo polarisation were limited to the description of gross morphological 
features and the characterization of microscopic cellular structures by bright field 
imaging. These studies suggested that the cell-contact free membranes of human 
blastomeres become re-arranged between embryonic days 3 and 4, concurrent with 
the commencement of embryo compaction16-18. To address whether these 
morphological rearrangements relate to cell polarisation, we used surplus, in vitro-
fertilised, cleavage-stage human embryos cryopreserved at embryonic day 3 and 
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cultured them until embryonic day 4 for analysis by time-lapse imaging and 
immunofluorescence (Fig. 1a). We first carried out morphokinetic analyses on a total 
of 260 vitrified day 3 human embryos that at the start of the experiment had a mean 
number of 8 cells - 7.97±1.22 total cells and 7.67 ± 1.59 intact (non-degenerated) cells 
that increased to approximately 12 cells -12.23 ± 3.07 total cells and 12.14 ± 3.05 
intact cells- after 24 hours in culture (Extended Data Fig. 1a-d). Interestingly, we found 
that the cell cycle time decreased from the 4/8-cell stage transition (22.15 hours ± 
0.9192) to the 8/16-cell stage transition (14.49 hours ± 4.189) (Extended Data Fig. 1e). 
The rate of cell degeneration was very low, with 89.4% of the embryos showing no 
signs of degenerated cells after warming and 95.2% of the embryos showing no 
degenerated cells after 24 hours of culture (N=85, Extended Data Fig. 1f, g), indicating 
that the high quality of the embryos was not compromised after embryo warming. To 
provide an objective assessment of the dynamics of compaction, we measured the 
inter-blastomere angle between adjacent blastomeres in a representative middle 
plane through the embryo. When this angle increased to greater than 120°, we 
concluded that cells had compacted, in agreement with previous reports6. We found 
that the average cell number at the start of compaction was 10.14 ± 2.5 (N=83), 
increasing to 11.57 ± 3.1 (N=54) by completion of compaction (Extended Data Fig. 
1h). In addition, we analysed compacting embryos in which the exact times of 
fertilisation and cryopreservation were known. This revealed that the completion of 
compaction was accomplished at 80.2 ± 8.5 hours post-fertilisation (h.p.f.) (Extended 
Data Fig. 1i-k). These observations indicate that the onset of compaction in human 
embryos is heterogeneous, and while it starts at the 8-cell stage, it extends to the 8/16-
cell stage. This is consistent with previous observations16,17,19 and contrasts with the 
timing of compaction in the mouse embryo where this process is completed by the end 
of the 8-cell stage6,20. Hence, the process of compaction in the human embryo is 
prolonged in comparison to the mouse embryo.  
 
We next wished to determine the sequence of developmental events ensuring human 
embryo polarisation in relation to compaction. In the mouse embryo, the polarisation 
of the Par complex to the apical domain serves as the crucial developmental transition 
that control the expression of TE lineage specific transcription factors4. Transcriptomic 
analyses indicate that Par complex components, such as PARD6, are also expressed 
in the human embryo at the 8-cell stage7,21. We therefore set out to determine the 
localisation of PARD6 during embryo compaction. Our recent studies in the mouse 
embryo revealed that the Par complex acquires apical localisation following two 
distinct steps. An initial apical enrichment of F-actin is concomitant with embryo 
compaction followed by the polarisation of the Par complex to the apical surface6. To 
determine whether this localisation pattern also occurs in the human embryo, we fixed 
embryos at three different time points during in vitro culture (2, 9 or 24 hours) and 
examined the localisation of PARD6 and F-actin (Fig. 1a). We found that F-actin 
localised circumferentially around the cell cortex and became apically enriched upon 
compaction. None of the embryos were compacted after 2 hours of culture in 
agreement with our time-lapse studies (N=18 embryos). At this stage, both cortical F-
actin and PARD6 were uniformly distributed within the embryos, indicating that they 
had not yet initiated polarisation (N=135 cells; 18 embryos) (Fig. 1b-d). However, 7 
hours later 26% of embryos had become fully compacted (N=199 cells; 19 embryos). 
All compacted cells displayed an apical enrichment of cortical F-actin at the cell-
contact free surface (Fig. 1b-d). In contrast, only half of these compacted cells showed 
PARD6 polarisation (26.3%, N=199 cells) (Fig. 1b-d). The proportion of compacted 
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embryos in which both F-actin and PARD6 were polarised increased significantly 
during the next 15 hours of culture (91.0% for compaction, N=11 embryos; 71.5% for 
PARD6 polarisation, N=628 cells) (Fig. 1b-d). Quantification of cell polarisation in 
embryos in which the exact times of fertilisation and cryopreservation were known 
revealed a similar pattern; none of the embryos showed F-actin nor PARD6 
polarisation (N=49 cells; 6 embryos) at 74-75 h.p.f; F-actin polarisation was observed 
at 77-80 h.p.f. (57.1%; N=21 cells; 2 embryos), while PARD6 polarisation was 
detected 93-97 h.p.f. (41.4%; N=99 cells; 9 embryos) (Fig. 1e-f). The level of PARD6 
apical enrichment, as well as the size of the PARD6 domain, showed a positive 
correlation with embryo cell numbers, indicating that the apical localisation of PARD6 
increases as embryos develop (Fig. 1g-h). We also confirmed that other components 
of the apical Par polarity complex such as atypical protein Kinase C (aPKC) localises 
to the cell-contact free surface at the same developmental time frame (N=5, Extended 
data Fig. 2a). Globally, these results indicate that polarisation of the human embryo 
follows two steps: in the first, F-actin becomes polarised concomitantly with embryo 
compaction, and in the second, the Par complex becomes polarised. 
 
We next wished to determine the mechanism of human embryo polarisation. Our 
recent studies in the mouse embryo showed that polarisation is regulated by the PLC-
Protein Kinase C (PKC) pathway, which enables the recruitment of the actin-myosin 
complex to the cell membrane6. We therefore analysed whether the PLC-PKC 
pathway is also responsible for polarisation of the human embryo. To address this 
question, we first cultured human embryos from day 3 in the presence of the PLC 
inhibitor U7312222 (Fig. 2a) using three different concentrations (5 μM, 7.5 μM and 10 
μM), and analysed the localisation of F-actin and PARD6. At the lowest concentrations 
(5 μM), U73122 failed to have an impact on cell polarisation (N=42 control embryos; 
N=19 DMSO-treated embryos; N=25 U73122-treated embryos), whereas at a higher 
concentration (7.5 μM) U73122 significantly reduced the proportion of polarised cells 
and the level of apical enrichment for PARD6 (N=42 control embryos; N=24 DMSO-
treated embryos; N=24 U73122-treated embryos) (Fig. 2b-f and Extended Data Fig. 
2b and 3a, b),  but without an obvious effect on embryo cell number (Fig. 2e), 
suggesting a specific effect of U73122 on cell polarisation. By contrast, high levels of 
PLC inhibitor (10 μM) affected embryo development and led to apoptosis (N=66 
control embryos; N=23 DMSO 5 μM-treated embryos; N=31 U73122 5 μM-treated 
embryos; N=20 DMSO 7.5 μM-treated embryos; N=20 U73122 7.5 μM-treated 
embryos; N=9 DMSO 10 μM-treated embryos; N=10 U73122 10 μM-treated embryos, 
Extended Data Fig. 3c). Based on these results, we carried out subsequent 
experiments using low concentrations of U73122 (5 μM and 7.5 μM). Next, we 
analysed whether the PLC pathway controls compaction. We observed a mild and 
non-statistically significant effect of PLC inhibition on the percentage of embryos that 
compacted during the first 24 hours of culture (N=66 control embryos; N=23 DMSO 5 
μM-treated embryos; N=31 U73122 5 μM-treated embryos; N=27 DMSO 7.5 μM-
treated embryos; N=27 U73122 7.5 μM-treated embryos Extended Data Fig. 3d). 
These results indicate that PLC is a major regulator of cell polarisation, but not of 
compaction. 
 
To substantiate the role of PLC in cell polarity establishment of the human embryo, 
we next used RNA interference (RNAi)23 to down-regulate PLC expression at the 
cleavage stage and determine its effects on embryo polarisation. Specifically, we 
chose to deplete PLCE1 and PLCB1, as the level of their mRNA expression rank the 
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highest among all functional PLC isoforms in human embryos between the 2- to the 
8-cell stage (Extended Data Fig. 3e)24. To validate the siRNAs, we either injected the 
siRNA into human embryos or transfected them into HeLa and 293T cells. These 
experiments revealed a 70% downregulation of PLCE1 and PLCB1 (Extended Data 
Fig. 3f). Next, we injected control and PLCE1/PLCB1 siRNAs into human embryos at 
the zygote stage and allowed them to develop until day 4 to analyse the localisation 
of PARD6. The analysis of PARD6 localisation by immunofluorescence revealed a 
significantly reduced number of polarised cells in PLCE1/PLCB1 siRNA embryos (Fig. 
2g-i; N=18 embryos for control siRNA embryos; N=12 embryos for PLCB1+PLCE1 
siRNA embryos), in agreement with the result of PLC inhibitor treatment. Thus, both 
the pharmacological and RNAi approach indicate that PLC activity regulates cell 
polarisation during early human embryo development.  
 
Finally, we wished to determine whether embryo polarisation is critical for initiation of 
cell fate specification. To address this question, we analysed the spatiotemporal 
expression of the transcription factor GATA3, which is a key marker of TE specification 
and based on single-cell RNA sequencing is already induced at the compacting morula 
stage7. We found that embryos lacked GATA3 expression after either 2 or 9 hours in 
culture, regardless of whether individual cells within the embryo were polarised or not 
(Fig. 3a-b, N=135 cells; 18 embryos for 2 hours and N=199 cells; 19 embryos for 9 
hours). In contrast, we detected GATA3 nuclear localisation in 53.5% of the cells after 
24 hours of culture, and therefore on day 4 (Fig. 3a-b, N=519 cells; 75 embryos). 
Strikingly, GATA3 was localised to the nucleus in both polarised and non-polarised 
cells, although the nuclear signal intensity of GATA3 was significantly higher in 
polarised cells. These results suggest that in human embryos GATA3 expression is 
initiated independently of embryo polarisation, but that its expression and nuclear 
localisation is reinforced by the acquisition of apicobasal polarity (Fig. 3a, c). To 
understand whether cell polarisation also promotes nuclear localisation of other TE 
transcription factors, we also examined the localisation of YAP1 in inner and outer 
polarised cells. We found that YAP1 was also significantly enriched in outer polarised 
cells in comparison to inner apolar cells (N=4 embryos; Extended Fig. 4a-b). These 
results suggest that cell polarisation promotes the accumulation of TE-associated 
transcription factors in the nucleus as early as the morula stage, similar to what 
happens in the mouse embryo.   
 
To further confirm the role of cell polarisation in the expression of TE transcription 
factors, we wished to analyse GATA3 expression after U73122 treatment, as this 
would inhibit PLC and therefore embryo polarisation.  To this end, we applied U73122 
at 5 μM and 7.5 μM, cultured the embryos from day 3 to 4 and analysed GATA3 
expression. We found that U73122 treatment led to a significant reduction of the 
nuclear GATA3 signal intensity (Fig. 3d-e, N=142 cells for control embryo; N=37 cells 
for DMSO 5 μM  treated group; N = 84 cells for DMSO 7.5 μM  group; N=56 cells for 
U73122 5 μM treated group; N = 90 cells for U73122 7.5 μM treated group), but it did 
not affect the number of GATA3 positive cells per embryo (Extended Data Fig. 4c, 
N=46 control embryos; N=19 DMSO 5 μM-treated embryos; N=27 U73122 5 μM-
treated embryos; N=24 DMSO 7.5 μM-treated embryos; and N=23 U73122 7.5 μM-
treated embryos). Together, these results demonstrate that the onset of expression of 
the critical TE determinant, GATA3, is controlled by a polarity-independent pathway, 
but the levels of nuclear GATA3 are reinforced by a polarity-dependent pathway25.  
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The fact that expression of the TE lineage determinant, GATA3, is initiated 
independently of embryo polarisation led us to examine when inside cells, precursors 
of the ICM, are first generated. In the mouse embryo, inside cells are produced after 
all blastomeres become polarised at the 8-cell stage and by subsequent cell divisions 
from the 8-cell to 16-cell stage4. Consequently, inner cells can only be observed in 
embryos having more than eight polarised cells, but whether the same is true in the 
human embryo remains unknown. To address this question, we first analysed the 
number of inside cells and their correlation with cell polarity in relation to overall cell 
numbers in fixed human embryos. Surprisingly, we found that in 37% of embryos, 
inside cells were present with less than eight outer polarised cells (Fig. 4a-b, N=27 
embryos). This suggests that the generation of inside cells in the human embryo might 
not require the preceding establishment of embryo polarisation. In addition, we found 
that the size of the inside cells was highly variable, ranging from 229.123 to 1896.4 
μm2 (Fig. 4c-d). This partially overlapped with the size of 8-cell stage blastomeres, 
which ranges from 895.432 to 2627.03 μm2 (Fig. 4d). Specifically, we found that 34% 
(18 out of 53 embryos) of inside cells were bigger than the smallest 8-cell stage 
blastomere analysed. This suggests that cells can be internalised without undertaking 
asymmetric cell division at the 8-cell to 16-cell stage transition. To directly assess this 
possibility, we performed time-lapse imaging of live fluorescently labelled human 
embryos to record cell positions during the process of compaction. To be able to follow 
cells in live embryos, we labelled the cell membrane using a live-membrane dye (FM 
4-64FX). From the 5 human embryos imaged, we found one embryo in which a cell 
became positioned to the inside compartment during the process of compaction 
(Extended Fig. 4d). Therefore, whereas polarisation and subsequent asymmetric cell 
divisions are critical to generate inside cells in mouse embryos, in human embryos 
inside cells can be generated independently of polarity and asymmetric cell divisions, 
revealing mechanistic differences of TE/ICM segregation between the two species. 
 
In summary, our results uncover the timing and the mechanism behind embryo 
polarisation and its function in the first lineage segregation in the human embryo (Fig. 
4e). We show that the mechanism that triggers embryo polarisation is evolutionarily 
conserved between mouse and human. However, we also show that the onset of cell 
fate specification – cell allocation and expression of lineage determining genes – is 
independent of cell polarisation. Instead, cell polarisation is needed to reinforce a TE 
fate, which becomes established at the blastocyst stage7. These results provide 
important insight into human embryo development at a stage when a crucial 
morphogenetic transition occurs. 
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Figure 1. Timing of compaction and polarisation in human embryos. a, Scheme 
for human embryo culture. Surplus in vitro fertilised human embryos were warmed at 
day 3, and cultured for 2, 9 or 24 hours(h) to examine the localisation of polarisation 
markers. b, Representative images of human embryos fixed at different 
developmental time-points (as shown in a) and immunostained for F-actin and 
PARD6b. Arrowheads indicate the apical domain.  c, Quantification of number of cells 
showing polarised or non-polarised F-actin in different developmental time-points. d, 
Quantification of number of cells showing polarised or non-polarised PARD6. For both 
c and d, the number in each bar represents the number of cells analysed. N=28 
embryos for 2 h post-warming; N=21 embryos for 9 h post-warming and N=65 embryos 
for 24 h post-warming. N=9 independent experiments. e, Quantification of the number 
of cells showing polarised or non-polarised F-actin in different post-fertilisation time-
points. f, Quantification of the number of cells showing polarised or non-polarised 
PARD6 in different post-fertilisation time-points. For both e and f, the number in each 
bar represents the number of cells analysed. N=6 74-75 h.p.f., N=2 77-78 h.p.f. and 
N=9 h.p.f. embryos. g, Correlation between F-actin/PARD6 apical enrichment and cell 
numbers. Apical enrichment of F-actin and PARD6 is measured as the ratio of signal 
intensity on the apical surface to the cell-cell contacts. Apical enrichment of F-actin 
and PARD6 increases as embryo cell numbers increase. h, Correlation between the 
length of the apical domain (based on the PARD6 immunostaining) and embryo cell 
numbers.  The length of the apical domain increases as the embryo cell number 
increase. Each dot represents one analysed cell. h.p.f.: hours post-fertilisation. 7 
independent experiments. Scale bars, 15 µm. 
 
Figure 2. PLC activity regulates cell polarisation in the human embryo. a, 
Scheme for PLC inhibitor treatment. b, Representative images of in vitro fertilised 
human embryos warmed at day 3, cultured for 24 h (see scheme in Fig. 1a) and treated 
with or without DMSO or U73122 at different concentrations to reveal the localisation 
of F-actin and PARD6. Arrowheads indicate the apical domain. c-d, Quantification of 
the percentage of embryos showing F-actin (c) and PARD6 (d) polarised cells in 
embryos from panel b. Embryos were binned into three different categories based on 
the ratio of polarised cells to total cell numbers as shown in Extended Data Fig. 3a. 
ns:non-significant, ****p<0.0001. Chi-Square test. N=42 control embryos, N=19 
DMSO 5µM embryos, N=25 U73122 5 µM embryos, N=20 DMSO 7.5µM embryos and 
N=17 U73122 7.5 µM embryos. e, Quantification of the total number of cells in 
embryos of panel b. Each dot represents one embryo. N= 55 embryos for media 
control group, N=22 embryos for DMSO 5µM, N=25 embryos for DMSO 7.5µM, N=22 
embryos for U73122 5µM and N=26 embryos for U73122 7.5µM. Data is shown as 
mean ± S.E.M. ns: non-significant, Kruskal-Wallis test.  f, Quantification of apical 
PARD6 fluorescence intensity in embryos from panel b. N=204 cells from 38 embryos 
for Media control; N=41 cells from 10 embryos for DMSO 5µM; N=158 cells from 17 
embryos for DMSO 7.5µM, N=72 cells from 14 embryos U73122 5µM and N=126 cells 
from 24 embryos U73122 7.5µM. Each dot represents one analysed cell. ***p<0.001, 
Kruskal-Wallis test with a multiple comparisons test. Data is shown as mean ±S.E.M. 
g, Scheme for human zygote injection of PLCE1/PLCB1 siRNA. h, Representative 
images for embryos injected with control siRNA or PLCE1/PLCB1 siRNA and cultured 
until embryonic day 4 to reveal localisation of F-actin, PARD6, and DAPI. i, 
Quantification of the percentage of embryos showing PARD6 polarised cells in 
embryos from panel h.  Number in each bar indicates the number of embryos analysed. 
N=18 embryos for control siRNA injected group; N = 12 for PLCB1 + PLCE1 siRNA 
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injected group. * p<0.05. Fisher’s exact test. 5 independent experiments for PLC 
inhibitory treatments and 3 independent experiments for PLCE1/PLCB1 siRNA 
injections. Scale bars, 15µm. 
 
Figure 3. GATA3 expression is initiated independently of cell polarisation. a, 
Representative images of in vitro fertilised human embryos warmed at day 3 and 
cultured for 2, 9 or 24 h (see scheme in Fig. 1a) to reveal the localisation of F-actin, 
PARD6 and GATA3. GATA3 expression was undetectable until 24 h post-warming. 
White arrowheads indicate outer cells; yellow arrowheads indicate inner cells. Inner 
cells also express GATA3 albeit at lower levels. b, Quantification of the number of 
GATA3 positive cells in embryos from panel a. Cells that have higher nuclear GATA3 
signal comparing to cytoplasm are categorised as GATA3+ cells. Numbers in each 
bar indicates the number of cells analysed. N=17 embryos for 2 h N=20 embryos for 
9 h and N=38 embryos for 24 h. c, Quantification of GATA3 nuclear signal in embryos 
from panel a. Each dot represents one cell. Data shown as mean ±S.E.M. The GATA3 
nuclear signal has been calculated as the nucleus to cytoplasmic signal ratio in each 
cell.  N=5 embryos for 2 h, N=5 embryos for 9 h and N=5 embryos for 24 h. **p<0.01; 
student’s t test. d, Representative images of embryos treated with different 
concentrations of U73122, cultured from day 3 to day 4 and stained for F-actin, PARD6 
and GATA3. e, Quantification of GATA3 nuclear signal intensity in embryos from panel 
d. N=142 cells from 18 embryos for Media control; N=37 cells from 6 embryos for 
DMSO 5 µM; N=84 cells from 12 embryos for DMSO 7.5 µM, N=56 cells from N=9 
embryos U73122 5 µM and N=90 cells from N=13 embryos U73122 7.5 µM. Each dot 
represents one cell analysed. ns: non-significant. **** p < 0.0001, Kruskal-Wallis test. 
2 independent experiments (a-c) and 5 independent experiments (d-e). Scale bars, 15 
µm. 
 
 
Figure 4. Inner cells in human embryo can be generated by a polarity 
independent mechanism. a, Representative images of embryos that have inner cells 
with low number of outer polarised cells. White arrowheads indicate the presence of 
inner cells. b, Line chart showing the relation between the number of inner cells, the 
number of PARD6 positive cells and total cell number in embryos that have inner cells. 
c, Representative images of embryos showing inner cells with different sizes. Dotted 
lines indicate the outline of the inner cells. d, Quantification of the distribution of the 
size of inner cells in comparison with the size of 8-cell stage blastomeres. N=53 inner 
cells from 21 embryos; and N=80 8-cell stage blastomeres from 10 embryos. e, Model 
summarising the main findings of this study. F-actin polarisation precedes Par 
complex polarisation and it is triggered by PLC activation. Blastomeres initiate 
expression of TE factors independently of the polarity machinery, but polarisation 
reinforces a TE fate. 5 independent experiments. Scale bars, 15 µm. 
 
 
Extended Data Figure Legends: 
 
Extended Data Figure 1: morpho-kinetic analysis of human embryos cultured in 
vitro from day 3 to day 4. a-b, Histograms showing the number of total (a) and intact 
(b) cells at the time of embryo warming, N=132 control embryos. c-d, Histograms 
showing the number of total (c) and intact (d) cells after 24 h of embryo culture, N=85 
control embryos. e, Cell cycle length shown at the 4 to 8 (t4-8) and 8 to 16 (t8-16) cell 
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stage transitions. Each dot represents an individual embryo. N=2 t4-8 and N=10 t8-16 
control embryos. Data is shown as mean ± S.D. f, Histogram showing the number of 
degenerated cells at the time of embryo warming, N=132 control embryos. g, 
Histogram showing the number of degenerated cells during 24 h of embryo culture, 
N=85 control embryos. h, Number of cells before and after compaction. Each dot 
represents an individual embryo. Data is shown as mean ± S.E.M. N=83 (before) and 
N=54 (after) control embryos. **p=0.0083, Mann Whitney U test. i, Brightfield images 
of an embryo undergoing compaction. The time post-fertilisation is indicated in h as 
h.p.f. The angle measured to assess compaction is indicated. Scale bars, 10 µm. j, 
Histogram showing the time period between the initiation and the end of compaction. 
N=50 control embryos. k, Time at which compaction is completed in embryos with 
known fertilisation time. N=4 control embryos. Data is shown as a box and whiskers 
plot from the minimum to the maximum value. 2 independent experiments. 
 
Extended Data Figure 2: localisation of polarisation proteins at the morula stage 
in human embryo. a, Human embryos at embryonic day 4 were immunostained with 
aPKC, F-actin and DAPI. aPKC localises to cell-contact free surface in a similar 
fashion with PARD6.N=5 embryos. b, Quantification of apical F-actin fluorescence 
intensity in embryos from Fig.2b. Each dot represents one analysed cell. N=204 cells 
from 38 embryos for Media control; N=41 cells from 10 embryos for DMSO 5µM; 
N=158 cells from 17 embryos for DMSO 7.5µM, N=72 cells from 14 embryos U73122 
5µM and N=126 cells from 24 embryos U73122 7.5µM. ***p<0.001, Kruskal-Wallis test. 
Scale bars, 15 µm. 
 
Extended Data Figure 3: morpho-kinetic analysis of WT and PLC inhibitor 
treated embryos. a-b, Histograms showing the ratio of F-actin (a) and Par6 (b) 
polarised cells in embryos from Fig. 2b. Data was binned into three different groups. 
c, Percentage of degenerated cells in embryos from Fig. 2b. Each dot represents an 
individual embryo. Data is shown as mean ± S.D. N=66 embryos (control), N=23 
embryos (DMSO 5 µM), N=31 embryos (U73122 5 µM), N=20 embryos (DMSO and 
U73122 7.5 µM), N=9 embryos (DMSO 10 µM) and N=10 embryos (U73122 10 µM). 
Kruskal-Wallis test with a multiple comparisons test. *p=0.0355, ns: non-significant. d, 
Compaction analysis in control and PLC inhibitor treated embryos. The specific 
number of embryos per category is indicated. Ns: non-significant, **p=0.0099. e, 
Expression profile for all PLC isoforms at different stages of human preimplantation 
development. Data retrieved from Yan et al., 2014. f, Expression level of PLCE1 and 
PLCB1 in human 3PN zygotes injected with control siRNA or PLCE1+ PLCB1 siRNA; 
or Hela and 293T cell lines transfected with control siRNA or PLCE1+PLCB1 siRNA 
and cultured for one day. PLCE1 expression is not calculated for human zygotes due 
to the low expression level. 
 
Extended Data Figure 4: YAP1 display a higher Nucleus-to-cytoplasmic ratio in 
polarised cells at the morula stage. a, Human embryos at embryonic day 4 were 
immunostained for YAP1, PARD6 and DAPI. White arrows indicate outer cells, yellow 
arrows indicate inner cells. b, Quantification of Nucleus-to-cytoplasmic ratio of YAP1 
in embryos from panel a. Each dot represents an analysed cell. N=22 polarised cells 
and N=18 unpolarised cells from 4 embryos analysed. ****p<0.0001, Mann-Whitney 
test. c, Quantification of fraction of GATA3+ positive cells for each embryo in different 
conditions shown in Fig. 3a.  d, time-lapse imaging of cell position in compaction 
process during human embryo development. After a cell division, one of the two 
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daughter cells was positioned to the inside of the embryo, and due to the compaction 
process this daughter cell was ultimately located to the inner position of the embryo. 
The dividing cell was labelled in yellow, and the two daughter cells were coloured with 
green and red. Red dotted lines indicate the red cell shown in 3D reconstruction. The 
red cell become localised to the inside. Scale bars, 15 µm. 
 
Material and Methods 
 
Ethical approval 
 
This study was performed in four avenues: Clinical Embryology Laboratory at IVIRMA 
Valencia (Spain), University of Cambridge (United Kingdom), National Research 
Center for Assisted Reproductive Technology and Reproductive Genetics (China), 
and California Institute of Technology (United States). 
  
The work in Clinical Embryology Laboratory at IVIRMA Valencia was approved by the 
National Commission of Human Reproduction (CNRHA), the General direction of 
research, innovation, technology and quality and by our institutional review board, the 
ethics committee of Clinical Research IVI Valencia, which complies with Spanish law 
on assisted reproductive technologies (14/2006).  A total of 260 donated day 3 human 
embryos from 95 IVF patients were used. The average age of women was 28.12 ± 4. 
The fixed embryos were analysed at the University of Cambridge. This work was 
evaluated by the Human Biology Research Ethics Committee of the University of 
Cambridge (reference HBREC.2017.27).  
 
The work performed at the University of Cambridge was in accordance with the Human 
Fertility and Embryology Authority (HFEA) regulations (license reference R0193). 
Ethical approval was obtained from the “Human Biology Research Ethics Committee” 
of the University of Cambridge (reference HBREC.2017.21). Informed consent was 
obtained from all patients from CARE Fertility Group and Herts & Essex fertility clinics, 
who donated surplus embryos used in this study after completing their IVF treatment. 
Prior to giving consent, patients were informed about the specific objectives of the 
project, and the conditions that apply within the license, offered counselling and did 
not receive any financial inducements. In this study, we used 15 donated embryos at 
the 2 pronuclei stage (day 1 d.p.f.), which were warmed and cultured in the Cambridge 
Laboratory according to the above regulations.  
 
The work performed in the National Research Center for Assisted Reproductive 
Technology and Reproductive Genetics was conducted under the regulations of the 
Human Biomedical Research Ethics Guidelines (regulated by National Health 
Commission of the People’s Republic of China on 1 December 2016), the 2016 
Guidelines for Stem Cell Research and Clinical Translation (issued by the International 
Society for Stem Cell Research, ISSCR) and the Human Embryonic Stem Cell 
Research Ethics Guidelines (regulated by China National Center for Biotechnology 
Development on 24 December 2003). These regulations and guidelines allow human 
gametes, and/or human embryos created or genetically manipulated in vitro and those 
cultured for no more than 14 days, to be used for scientific researches. The aim and 
protocols involved in this study were reviewed and approved by the Institutional 
Review Board of Reproductive Medicine, Shandong University. The protocols include 
the siRNA injection of human embryos. 
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The work at California Institute of Technology was approved by the California Institute 
of Technology Committee for the Protection of Human Subjects (Institutional Review 
Board number 19-0948). Funding was obtained through Open Philanthropy Project 
fund at the Silicon Valley Community Foundation. Human embryos at the zygote stage 
were obtained from the University of Southern California (USC) through the pre-
existing USC Institutional Review Board-approved Biospecimen Repository for 
Reproductive Research (HS-15-00859) after appropriate approval was obtained 
unanimously from the Biorepository Ethics Committee.  
 
Patient and embryo selection 
 
In IVIRMA Valencia the majority of the day-3 embryos used in this study were 
generated by intracytoplasmic sperm injection (ICSI) (76.2%=198/260) using donor 
eggs (72.7%=189/260). The mean age of female patients providing oocytes was 28.12 
± 4 years (N=260), which is one of the strongest predictors of embryonic competence 
and oocyte quality26. The mean age of male patients providing sperm was 40.8 ± 6.98 
years (N=260). The mean cell number at the time of embryo warming was 7.98 ± 1.26 
(N=260), which is consistent with the 8 cells expected on day-3 stage of development 
of a good quality human embryo27. Most common female indications for Assisted 
Reproductive Technology included age (55%=143/260), poor ovarian response 
(8.1%=21/260) and tubal factor (7.7%=20/260). 
 
All embryos used in National Research Center for Assisted Reproductive Technology 
and Reproductive Genetics were donated surplus 3PN zygotes generated from in vitro 
fertilisation, with the donor females age from 22 to 40 years old.  The newly generated 
and donated 3PN embryos were used directly for microinjection experiments.  
 
For embryos used in USC, all participants gave prior informed consent at USC Fertility 
to donate surplus cryopreserved embryos to research protocols after completion of 
childbearing or IVF treatment. Patients donated embryos of their own volition without 
coercion and did not receive any financial compensation for participation. A total of 41 
donated human embryos at the zygote stage 2 pronuclei stage (day 1 d.p.f.) from 4 
IVF patients were used. The average age of women was 44. The embryos were 
warmed at USC Fertility per usual IVF procedure and then transferred to the California 
Institute of Technology for the remainder of the protocol. 
 
Embryo warming and culture conditions 
 
For experiments performed in Clinical Embryology Laboratory at IVIRMA Valencia: 
Vitrification and warming procedures were performed by means of the Kitazato 
method, as described elsewhere28,29. Briefly, embryos were equilibrated at room 
temperature in 7.5% (vol/vol) ethylene glycol + 7.5% dimethylsulfoxide (DMSO). After 
volume re-expansion, embryos were transferred to the vitrification solution consisting 
of 15% ethylene glycol + 15% DMSO + 0.5 M sucrose. After 1 min in this solution, 
embryos were placed on the Cryotop device using a minimum volume and were 
directly submerged in liquid nitrogen. For warming, the Cryotop was removed from 
liquid nitrogen and placed in 1.0 M sucrose in tissue culture media M 199 + 20% 
synthetic serum substitute (SSS) at 37°C. After 1 min, embryos were transferred to a 
solution containing 0.5 M sucrose at room temperature for 3 min. After two washes of 
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5 and 1 min, each in TCM199, embryos were cultured in a Geri Dish® at 5.5 % CO2, 
5% O2 and 37ºC, humidified environment in a time lapse incubator Geri® (Genea 
Biomedx, Australia). Embryos were cultured for 2, 9 or 24 h in pre-equilibrated Sydney 
IVF Blastocyst Medium (Cook, USA) or in the same medium supplemented with either 
U73122 - a PLC inhibitor (Caymanchem, USA, in 35 or 53mM DMSO) or DMSO (35 
or 53mM, Sigma, USA) as vehicle control, without mineral oil. All culture media were 
pre-equilibrated to the incubator’s conditions overnight (5.5% CO2, 5% O2 and 37ºC, 
humidified environment).  
 
For the experiment performed at the University of Cambridge: Cryopreserved day 1 
embryos were warmed using Origio thaw kit (REF10984010A)) following the 
manufacturer’s instructions. Briefly, the day before warming, Global Total human 
embryo culture medium (HGGT-030, LifeGlobal group) was incubated at 37°C + 5% 
CO2. Upon warming, the straw containing the embryo was defrosted at room 
temperature for 30 sec, and immersed in prewarmed (37°C) water for 1 min. The 
embryo was then transferred into vial 1 (5min), vial 2 (5 min), vial 3 (10 min) and finally 
in vial 4 for slow warming procedure. All these incubation steps were done using 12 
well plates (ThermoFisher, 150628) and 1 ml per solution. Warmed embryos were 
finally incubated in drops of pre-equilibrated Global Total human embryo culture 
medium under mineral oil (9305, Irvine Scientific). Culture conditions are the following: 
37°C 21% O2 and 5% CO2. Embryos were incubated for a total of 48 h in Global 
reaching 6-8 cell stage (day 3). At day 3 the embryos were either transferred into 96-
well plate with each well containing 200 μl solution: control group (Global medium only), 
treated group (Global medium + PLC inhibitor at the concentration of 7.5μM, or to 
transfer to medium containing 35ng/ml FM 4-64FX for live-imaging. Embryos were 
stopped after 24 h culture via 4% PFA fixation. 
 
For the experiment performed at California Institute of Technology, the embryos were 
warmed using Embryo Thaw Media Kit following the manufacturer’s instructions 
(Fujifilm Irvine Scientific,  Cat. No. 90124). The day before warming, Continuous 
Single Culture-NX Complete medium (Fujifilm Irvine Scientific, Catalog No: 90168) 
was equilibrated overnight at 37°C + 5% CO2. On the day of warming (day 1), the 
straw that contains the embryo was defrosted at room temperature for 30 sec and 
immersed in prewarmed (37°C) water for 1 min until ice melted. The embryo was then 
transferred into T-1 (5 min), T-2 (5 min), T-3 (10 min) solutions for slow warming and 
finally into Multipurpose Handling Medium (MHM, Fujifilm Irvine Scientific, Cat. No. 
90163) for recovery. All these incubation steps were done using 4 well plates (Nunc) 
and 1 ml per solution. Warmed embryos were finally incubated in drops of pre-
equilibrated Continuous Single Culture-NX Complete medium under mineral oil (9305, 
Irvine Scientific). Culture conditions are the following: 37°C 21% O2 and 5% CO2. 
Embryos were incubated for a total of 48 h until reaching the morula stage (day 4). 
Embryos were fixed with 4% PFA at day 4 for immunofluorescence analysis. 
 
 
Experimental setting 
 
A total of 60 day 3 embryos were cultured for 2 (N=21 embryos), 9 (N=26 embryos) 
and 24 h (N=13 embryos) after warming. Following fixation in 4% PFA, the compaction 
and polarisation timings of the human embryos were assessed by 
immunofluorescence analysis and time-lapse imaging evaluation.  
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To test the role of PLC, 8 experiments were performed with a total of 208 day 3 human 
embryos, which were warmed and randomly allocated into one of the following 
experimental groups: 5 μM U73122 (N=36), culture medium control (N=36) and 
vehicle control (N=23). Three additional series using increasing concentrations of 
U73122 were also performed: 7.5 μM U73122 (N=33), and its respective culture 
medium control (N=26) and vehicle control (N=25); and 10 μM U73122 (N=10), and 
its respective culture medium control (N=10) and vehicle control (N=9). All embryos 
were cultured for 24 h and fixed in 4% paraformaldehyde (PFA) to analyse cell 
polarisation and TE specification.  
 
Embryo development was recorded in a Geri incubator (Genea Biomedx, Australia), 
which was programmed to acquire images of each embryo every 15 min through 11 
different focal planes. The time-lapse videos of embryo development were analysed 
using the manual annotation software Geri Assess® 1.0 (Genea Biomedx, Australia). 
The morphokinetic analysis was performed from the moment of embryo warming (Day 
3) until embryo fixation at 2, 9 or 24 h after warming.  
 
Human embryo microinjection 
For the siRNA microinjection experiment performed at the National Research Center 
for Assisted Reproductive Technology and Reproductive Genetics, in-vitro fertilised 
3PN zygotes were injected and cultured in G1.5 medium (Vitrolife, cat. no.10128);  for 
siRNA microinjection experiment performed at California Institute of Technology, the 
warmed embryos at 2PN stage were placed in MHM and microinjections were 
performed in MHM. Embryos were then cultured in drops of pre-equilibrated medium 
overlaid with mineral oil as described above.  
The following siRNAs were used for microinjection: human PLCB1 siRNA #1 
(CACACTACCAAGTATAATGAA) (Qiagen, Hs_PLCB1_4, SI00115521); PLCB1 
siRNA #2 (CAGAGATGATCGGTCATATA) (Qiagen, Hs_PLCB1_6, SI02781184); 
PLCE1 siRNA#1(CAGGGTCTTGCCAGTCGACTA) (Qiagen, Hs_PLCE1_1, 
SI00115521); negative control siRNA (UUCUCCGAACGUGUCACGUdTdT) (Qiagen, 
1022076). A 20μM concentration of siRNA solution was used for injection.  
 
Embryo fixation and Immunofluorescence 
After culture, embryos were washed in PBS (Sigma, cat. no. D8537) and fixed in a 
freshly-prepared PBS solution containing 4% PFA (EMS, cat. no. 15710) for 20 min. 
For experiments done in IVIRMA Valencia, fixed embryos were washed twice in a PBS 
solution containing 0.1% Tween-20 (Sigma, cat. no. P9416) and immediately placed 
into a 0.5 ml PCR tube within an oil-PBS-oil interphase. Tubes were stored at 4ºC 
were shipped to the University of Cambridge for immunofluorescence. For 
experiments done in other avenues, the embryos were directly processed for the 
subsequent steps.  
 
A total of 203/266 embryos were subjected to immunofluorescence. Embryos were 
permeabilised in PBS containing 0.3% Triton X-100 and 0.1 M glycine for 20 min at 
room temperature. They were incubated in blocking buffer (PBS containing 10% BSA 
and 0.1% Tween) for 1 h. Primary antibodies were incubated overnight at 4°C in 
blocking buffer and secondary antibodies were incubated at room temperature for 2 h 
in blocking buffer. The following antibodies were used:  
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Primary antibodies: 
Rabbit anti-PARD6(1:200)(Santa Cruz, sc-166405); 
Goat anti-GATA3(1:200)(Thermo Fisher, MA1-028); 
Mouse anti-aPKC(1:50)(Santa Cruz, sc-17781); 
Mouse anti-YAP1(1:200) (Santa Cruz, sc-101199). 
 
Secondary antibodies:  
Alexa Fluor® 568 Donkey anti-Goat; 
Alexa Fluor® 568 Donkey anti-Mouse; 
Alexa Fluor® 647 Donkey anti-Rabbit. 
Alexa Fluor® 647 Donkey anti-mouse. 
In addition, embryos were stained with Alexa Fluor® 488 Phalloidin (A12379, 
ThermoFisher Scientific) to reveal the F-actin cytoskeleton and with DAPI (D3571, 
ThermoFisher Scientific) to reveal nuclei.  
Images were taken on an SP5 confocal microscope (Leica Microsystems) using a 40x 
oil objective N.A = 1.2. Laser power (less than 10%) and gain were kept consistent 
across different samples from the same experiment.  
The images provided for siRNA injection experiments were taken on either an Andor 
Dragonfly spinning disc confocal microscope (63x oil objective N.A =1.4), or Sp8 
confocal microscopy (Leica Microsystems) using a 40x oil objective N.A = 1.10.  
 
Cell culture, Transfection of small interfering (si) RNA with liposome 
293 cells or HeLa cells were cultured in Dulbecco’s-modified Eagle’s medium 
(Invitrogencat. no. C11995500BT) added with 10% fetal bovine serum (FBS: Gibco 
cat. no. A3160801) and 1% penicillin-streptomycin solution (Gibco, cat. no.15140122) 
at 37◦C with 5% CO2. Transfections of siRNA were performed using Lipofectamine 
3000 (Invitrogen, cat.no. L3000-015, Carlsbad, CA, USA) according to the 
manufacturer's instructions. 293 cells or HeLa cells (1.6× 10^5) were plated onto 12-
well plates and cultured until they were 60-70% confluent. After refreshing the medium, 
we mixed Lipofectamine 3000 and siRNA (Qiagen, Hs_PLCB1_4, SI00115521; 
Qiagen, Hs_PLCB1_6, SI02781184; Qiagen, Hs_PLCE1_1, SI00115521; Qiagen, 
negative control siRNA, 1022076) against target genes with Opti-MEM (Gibco) and 
the mixture of either control siRNA or PLCE1+PLCB1 siRNA were evenly added into 
each well. 293 cells or HeLa cells were further cultured for 24h to analyse the gene 
expression by qRT-PCR.  
 
RNA extraction and qRT-PCR validation 
For 293 cells or Hela Cells, the RNeasy plus Micro Kit (Qiagen, cat. no.74034) was 
used for the extraction of total RNA following the manufacturer’s instructions. Genomic 
DNA was removed by digesting with RNase-free genomic DNA eraser buffer (Qiagen), 
and cDNA was obtained by reverse transcription of RNA using Evo M-MLV RT Kit for 
PCR Kit (Accurate Biotechnology(Human)Co.,LTD, cat. no. AG11603). 
 
For human embryos, the zona pellucida was removed by mechanical dissection with 
a glass needle. Embryos were washed several times by gentle pipetting with a narrow-
bore glass pipette to remove the attached cumulus or polar bodies. After final washing 
with 0.1% BSA/PBS three times, the embryos were collected and lysed in 2μl lysis 
buffer (0.2% Triton X-100 and 2 IU/μl RNase inhibitor) followed by reverse 
transcription with the SuperScript III reverse transcriptase. The PCR products were 
used for the templates of RT–PCR. 
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Power SYBR Green Master Mix (Takara) was used on a Roche 480 PCR system for 
qRT-PCR analysis. The mRNA level was calculated by normalising to the endogenous 
mRNA level of GAPDH (internal control) using Microsoft Excel. The qRT-PCR 
reactions were performed in triplicate for each experiment using gene-specific 
primers.The following primers have been used for qPCR: GAPDH: forward: 
GATCATCAGCAATGCCTCCT; reverse: TTCAGCTCAGGGATGACCTT; PLCB1: 
forward: GGAAGCGGCAAAAAGAAGCTC; reverse: CGTCGTCGTCACTTTCCGT; 
PLCE1: forward: TGCAGCCTCTCATCCAGTT; reverse: 
CCCTGCGGTAAATAGTCTGC.  
 
 
Data analysis 
 
Time lapse imaging: Since the exact times of cryopreservation were not available in 
most cases, the following variables were assessed from the time of warming (t0) by 
means of time-lapse imaging: number of intact and degenerated cells, defined as the 
number of apparent viable and degenerated cells, respectively; number of total cells, 
defined as the sum of intact and degenerated cells; degree of fragmentation, defined 
as the estimated percentage of the embryonic volume occupied by cellular fragments; 
number of degenerating cells; defined as the number of cells degenerating during 
embryo culture; cell cycle length, defined as the time in hours between two 
consecutive cytokinesis in a given blastomere; time to the start of compaction, defined 
as the first time point after warming at which two adjacent blastomeres displayed an 
increased inter-blastomere angle; time to the end of compaction, defined as the first 
time point after warming at which all blastomeres displayed an increased inter-
blastomere angle; duration of compaction, defined as the time interval between the 
start and end of compaction; number of cells at the start and end of compaction; and 
number of cells after embryo culture. Cell numbers shown in Extended Data Fig. 1 
have been obtained using time-lapse images. To calculate cell numbers after 
compaction and after embryo culture, the number of cell divisions throughout the 
compaction stage and throughout the whole embryo culture were added to the number 
of cells before compaction and to the number of cells after warming, respectively. 
Hence, since some cell divisions may be untraceable when occurring inside the 
compacting embryonic mass, real cell numbers may be higher than reported.  	
 
All immunofluorescence images were analysed using Fiji30. 
 
Apical enrichment analysis: F-actin and PARD6 polarisation were measured in a 
single focal plane, by taking the middle plane of the embryo. A freehand line of the 
width of 0.5μm was drawn along the cell-contact free surface (apical domain), or 
cell-contact (basal) area of the cell, signal intensity was obtained via the Region of 
Interest (ROI) function of Fiji. The apical/basal signal intensity ratio is calculated as: 
I(apical)/I(basal). A cell is defined as polarised when the ratio between the apical 
membrane and the cytoplasm signal intensity exceeds 1.5.  
 
GATA3 expression analysis:  the nucleus of each cells are masked using the Region 
of Interest (ROI) tool of Fiji. The average signal intensity of the ROI is calculated and 
a cell is defined as GATA3 positive when the nucleus to cytoplasm signal intensity 
exceeds 1.5.  
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Cell position analysis: embryos were imaged across their entire Z volume. By 
looking at F-actin localisation, the area of the cell of interest was examined on each 
plane. Cells that had an area exposed to the outside were defined as outer cells, 
whereas cells that did not have an area exposed to the outside were defined as 
inner cells. 
 
Cell size measurements: we analysed the size of blastomeres in 8-cell stage human 
embryos (reference) and in human embryos harbouring inside cells. Cell size was 
measured in a representative single plane using the F-actin channel and manually 
drawing the contour of the cells.  
 
Inter-blastomere angle: to measure the angle between two adjacent blastomeres 
we used the angle tool in Fiji and applied it to interfaces between blastomeres that 
were clearly visible in a given Z plane. 120° was chosen as a cut-off. The initiation 
of compaction was established as the time point at which one of the inter-blastomere 
angles in an embryo was above 120°. The end of completion of compaction was 
established as the time point at which all inter-blastomere angles in an embryo were 
above 120°.  
 
3D reconstruction and Segmentation: for 3D reconstruction images provided in 
Extended Fig. 4d, the membrane region of each cell at each plane was determined 
by FM-464FX signal, and the region of a cell across all planes were segmented 
manually using Fiji, the segmented masks were then transferred to 3D slicer 
software for the generation of 3D reconstructed images.    
 
Statistics and reproducibility 
 
Statistical analyses were done using GraphPad Prism. Investigators were not blind to 
group allocation. Sample size was not pre-defined and embryos were randomly 
allocated into different experimental groups. Qualitative data was analysed using a 
Chi-square test. Quantitative data that presented a normal distribution was analysed 
using a two-tailed Student’s t test or an ANOVA test. Quantitative data that did not 
present a normal distribution was analysed using a Mann Whitney U test or a Kruskal 
Wallis test.  
 
 
Data availability 
 
Data is available from the corresponding author upon request.  
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